This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Driven by an older, more diverse population, along with a significant increase in riskfactors including high blood pressure and obesity, total costs related to cardiovasculardisease (CVD) conditions are likely to triple by 2050, according to recent projections. At least 6 in 10 U.S.
ET Tuesday, June 4, 2024 DALLAS, June 4, 2024 — Driven by an older, more diverse population, along with a significant increase in riskfactors including high blood pressure and obesity, total costs related to. Embargoed until 4 a.m.
Nature Reviews Cardiology, Published online: 10 April 2024; doi:10.1038/s41569-024-01017-x Patients with cardiovasculardisease (CVD) have an increased risk of cancer, and patients with cancer have an increased risk of CVD.
Cardiovasculardisease (CVD) remains a global health burden despite advances in prevention and treatment. Conventional biomarkers, while effective for a number of patient groups, fail to provide personalized diagnosis and prognosis, necessitating the exploration of novel markers.
Chronic, low-level lead poisoning is a major riskfactor for cardiovasculardisease in adults and cognitive deficits in children, even at levels previously thought to be safe, according to a paper by Columbia University Mailman School of Public Health, Simon Fraser University in Canada, and Harvard Medical School, and Boston Children's Hospital.
The five classic riskfactors for cardiovasculardisease are well knownsmoking, high blood pressure, high cholesterol, diabetes, and underweight or overweight/obesity. All increase the likelihood of heart ailments down the road.
Men with cardiovasculardiseaseriskfactors, including obesity, face brain health decline a decade earlier—from their mid 50s to mid 70s—than similarly affected women who are most susceptible from their mid 60s to mid 70s, suggest the findings of a long term study, published online in the Journal of Neurology Neurosurgery & Psychiatry.
In recent years, the incidence of cardiovasculardisease (CVD) has risen steadily, significantly impacting public health. Subclinical hypothyroidism (SCH) remains a controversial riskfactor for CVD.
Cardiovascular mortality is still excessively high, despite the considerable progress made in the prevention and treatment of cardiovasculardiseases. Although many cardiovascularriskfactors (such as arterial hypertension, hypercholesterolemia, diabetes, etc.),
Metal exposure from environmental pollution is associated with increased calcium buildup in the coronary arteries at a level comparable to traditional riskfactors, according to a new study.
However, it remains unclear which type of exercise is most effective for managing AS, particularly in individuals at high risk for cardiovasculardiseases (CVD). BackgroundPrevious studies have shown that exercise can improve arterial stiffness (AS).
Nature Reviews Cardiology, Published online: 23 January 2025; doi:10.1038/s41569-025-01121-6 In this Review, Wu and colleagues discuss the evolution in cannabis regulation, the endocannabinoid system and cannabinoid receptors, the influence of cannabis on cardiovascularriskfactors, and the effects of traditional and synthetic cannabinoids on cardiovascular (..)
Prevalences of coronary disease (7.8% to 2.4%), and total cardiovasculardisease (11.3% The prevalences of poor diet, inadequate physical activity, and smoking are estimated to improve over time, whereas inadequate sleep will worsen. to 9.2%), heart failure (2.7% to 3.8%), stroke (3.9% to 6.4%), atrial fibrillation (1.7%
And plaque in your coronary arteries is the result of exposure to riskfactors over time. These individuals then must have had one or more riskfactors for a long time prior to their heart attack. 2 You will not know you have heart disease by waiting for symptoms. The answer: RiskFactors.
Research Highlights: Asian American adults with more unfavorable factors related to income level, education, housing, access to health care and other social variables had a greater likelihood of having riskfactors for cardiovasculardisease in this.
ABSTRACT: Albuminuria, an established biomarker of the progression of chronic kidney disease, is also recognized as a biomarker for the risk of cardiovasculardisease. Elevated urinary albumin excretion indicates kidney damage and systemic vascular disease, including myocardial capillary disease and arterial stiffness.
A world without cardiovasculardisease (CVD) is possible, yet millions of lives are lost prematurely to heart disease each year, according to the new report.
Getty Images mtaschetta-millane Tue, 07/09/2024 - 07:23 July 9, 2024 — Disparities in cardiovasculardisease outcomes between urban and rural areas continue to widen, yet nearly half of U.S. and those in the South had the highest cardiovascularrisk index. counties do not have a practicing cardiologist. miles vs 87.1
BackgroundThe relationship between resting heart rate (RHR) and the risk of end‐stage renal disease (ESRD) among those without cardiovasculardisease remains unclear. The risk of ESRD remained significantly elevated (HR, 1.32 [95% CI, 1.10–1.58]
The changing epidemiological landscape of cardiovasculardisease (CVD) and associated riskfactors has led to efforts to develop improved preventive approaches for short-term and long-term risk estimation.
Resistance training not only can improve or maintain muscle mass and strength, but also has favorable physiological and clinical effects on cardiovasculardisease and riskfactors. We also address the utility of resistance training for promoting cardiovascular health in varied healthy and clinical populations.
Research Highlights: People living in neighborhoods with more environmental adversities, including pollution, toxic sites, high traffic and few parks, had higher rates of cardiovasculardisease and cardiovasculardiseaseriskfactors. This association.
Cardiovasculardisease represents a significant riskfactor for mortality in individuals with type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL) is believed to play a crucial role in maintaining c.
Background Current clinical guidelines on cardiovasculardisease (CVD) do not specifically address the female population. The aim of this consensus is to know the opinion of a group of experts on the management of CVD in women. Results After two rounds, consensus in agreement was reached on 27 items (61.4%).
Atherosclerosis (ASVD) remains a leading driver of cardiovasculardisease (CVD), a global health challenge that claims millions of lives each year. Explore actionable, evidence-based strategies to combat traditional and emerging riskfactors, with a focus on precision approaches and primordial prevention.
Heersink School of Medicine have unveiled critical insights into the influence of high-proportion spliced-in titin truncating variants, or hiPSI TTNtv, on cardiovasculardiseaserisk. Physician-scientists from the University of Alabama at Birmingham Marnix E.
ObjectiveAdvanced glycation end-products (AGEs) may contribute to the pathogenesis of atherosclerotic cardiovasculardisease (ASCVD), potentially influencing its development and progression differently at various life stages. ASCVD risk was assessed by a validated Framingham risk score calculator.
Background and aims In the non-metropolitan region of Brandenburg (Germany), which is characterized by high rates of cardiovasculardiseases and underserved medical care, there is a lack of awareness regarding lipoprotein(a) [Lp(a)] as a riskfactor. 3.95, p = 0.003). vs. 45.8%; 17.6% vs. 13.9%, p = 0.001).
Nature Reviews Cardiology, Published online: 17 September 2024; doi:10.1038/s41569-024-01070-6 The gut microbiota has emerged as a riskfactor that affects thrombotic phenotypes in several cardiovasculardiseases.
BackgroundMajor depressive disorder (MDD) has been identified as a causal riskfactor for multiple forms of cardiovasculardisease. Journal of the American Heart Association, Ahead of Print.
This cross-sectional study uses the 2022 National Health Interview Survey to compare rates of cardiometabolic riskfactors and cardiovasculardiseases between rural and urban US adults and to evaluate the extent to which health care access, lifestyle factors, and social riskfactors contribute to rural-urban differences.
Research Highlights: The prevalence of cardiovasculardiseaseriskfactors varies greatly among Asian American, Native Hawaiian and other Pacific Islander (AANHPI) populations, according to an analysis of electronic health records for more than.
The human capital approach was used to estimate productivity losses from morbidity and premature mortality due to cardiovascular conditions.RESULTS:One in 3 US adults received care for a cardiovascularriskfactor or condition in 2020.
T2signal ratios were not associated with prevalent coronary heart disease (allP>0.05), but CIs were wide.ConclusionsUsing a wellestablished study of cardiovasculardisease development, we found evidence linking hypothalamic gliosis to multiple cardiovasculardiseaseriskfactors, independent of adiposity.
A world without cardiovasculardisease (CVD) is possible, yet millions of lives are lost prematurely to heart disease each year, according to the new Global Burden of Disease (GBD) special report published in the Journal of the American College of Cardiology.
Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovasculardisease, cognitive impairment, and frailty also share the following riskfactors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.
The triglyceride-glucose (TyG) index is recognized as an indicator of insulin resistance and is linked to cardiovasculardisease (CVD) in patients with type 2 diabetes. However, its utility in patients with Ty.
Research Highlights: The oral medication muvalaplin may safely lower high levels of lipoprotein(a), also known as Lp(a), an independent, inherited riskfactor for cardiovasculardisease. Muvalaplin is a small molecule inhibitor that prevents the.
Panelists discuss how cardiovasculardisease remains a leading health concern in the United States, examining its rising prevalence, riskfactors such as dyslipidemia, and management strategies aligned with AHA guidelines to reduce patient mortality.
Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not well defined. This study aimed to evaluate the riskfactors associated with LV mass and subclinical coronary atherosclerosis, in an Asian population free of baseline cardiovasculardisease.
Healthy sleep includes multiple components, such as number of hours of sleep per night, how long it takes to fall asleep, daytime functioning and self-reported sleep satisfaction, and addressing these different dimensions of sleep may help to reduce cardiometabolic health and related riskfactors, according to a new scientific statement.
BackgroundType 2 diabetes (T2D) is a major riskfactor for atherosclerotic cardiovasculardisease (ASCVD). This study examined the interplay between watching television and T2D genetic risk for risk of ASCVD.MethodsWe included 346 916 White British individuals from UK Biobank.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content